Benzinga
Benzinga
Actualités France
Bourse
Economie
Général
Actualités Américaines
Bourse
Bénéfices
Economie
Marchés prédictifs
Marchés privés
Autres marchés
Recommandations des analystes
Trading
Communiqués de presse
Mondial
Asie
Crypto-monnaies
Actualités cryptos
Altcoins
Bitcoin
Dogecoin
Ethereum
Shiba Inu
NFT
Éducation
Investir en crypto
Investir en bourse
Forex
Benzinga
lundi, novembre 16
Actualités France
Bourse
Economie
Général
Actualités Américaines
Bourse
Bénéfices
Economie
Marchés prédictifs
Marchés privés
Autres marchés
Recommandations des analystes
Trading
Communiqués de presse
Mondial
Asie
Crypto-monnaies
Actualités cryptos
Altcoins
Bitcoin
Dogecoin
Ethereum
Shiba Inu
NFT
Éducation
Investir en crypto
Investir en bourse
Forex
Faeth Therapeutics Inc
FTH
NASDAQ
Liste de surveillance
Get Report
Trade with Public
Get Report
Trade with Public
$9.28
-0.75
-7.48%
À la clôture: Nov 16, 4:00 PM EST
$9.23
-0.05
-0.54%
Après les heures: 4:14 PM EST
Get Report
Aperçu
Actualités
Graphiques
Prévisions de résultats
Événements
Objectifs de cours
Données financières
Sentiment
Actionnariat
Comparer
Options
Rapport sur les stocks
Faeth Therapeutics Financials
Faeth Therapeutics (FTH) financial statements — income, revenue, gross margin and key metrics.
Earnings & Guidance News
Crude Oil Falls Over 3%; NRG Energy Shares Jump After Strong Q3 Results
U.S. stocks surged Monday, led by a 2.1% S&P 500 gain; NRG jumped on strong results, while Zura Bio plunged 75% after trial failures.
Avi Kapoor
Dow Jumps Over 600 Points; Constellation Energy Posts Upbeat Earnings
U.S. stocks rallied Monday, led by tech and consumer discretionary shares. Constellation Energy beat Q3 estimates; oil fell while gold rose.
Avi Kapoor
PRO
Faeth Therapeutics Q3 EPS $(0.79) Misses $(0.71) Estimate
Faeth Therapeutics (NASDAQ:FTH) reported quarterly losses of $(0.79) per share which missed the analyst consensus estimate of $(0.71) by 11.27 percent. This is a 78.18 percent increase over losses of $(3.62) per share
Benzinga Newsdesk
PRO
Faeth Therapeutics Q2 EPS $(2.84) Beats $(3.29) Estimate
Faeth Therapeutics (NASDAQ:FTH) reported quarterly losses of $(2.84) per share which beat the analyst consensus estimate of $(3.29) by 13.68 percent. This is a 27.37 percent increase over losses of $(3.91) per share
Benzinga Newsdesk